Submissions from 2024
Topical Nanoencapsulated Cannabidiol Cream as an Innovative Strategy Combatting Ultraviolet A-Induced Nuclear and Mitochondrial DNA Injury: A Pilot Randomized Clinical Study, Erika McCormick, Haowei Han, Sara Abdel Azim, Cleo Whiting, Nitish Bhamidipati, Alexi Kiss, Tatiana Efimova, Brian Berman, and Adam Friedman
Insights from a joint pediatric dermatology-gynecology vulvar clinic: A retrospective study, Nikita Menta, Dillon Nussbaum, Aneka Khilnani, Tazim Dowlut-McElroy, and Kaiane A. Habeshian
Atopic Dermatitis: A Disorder of both Adults and Children with Varying Longitudinal Course, Shanthi Narla and Jonathan I. Silverberg
Bed Bugs, Scott A. Norton and Richard J. Pollack
Bed Bugs, Scott A. Norton and Richard J. Pollack
Reducing disparities in the care of atopic dermatitis, Uchechi Nwaneri, Candrice Heath, Andrew Alexis, Adam Friedman, and Jonathan I. Silverberg
Association between body mass index and vitiligo distribution: An observational cohort study, Ross O'Hagan, Samir Kamat, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
An observational cohort study of body mass index in pediatric vitiligo, Ross O'Hagan, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
An observational cohort study of body mass index in pediatric vitiligo, Ross O'Hagan, Shira Wieder, Marcel Perl, Jonathan I. Silverberg, and Nanette B. Silverberg
Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis, Amy S. Paller, Lawrence J. Green, Nanette Silverberg, Stephen Stripling, Martina Cartwright, Carolyn Enloe, Nick Wells, Elaine Kearney Kowalewski, and Tomoko Maeda-Chubachi
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 years, Amy S. Paller, Jonathan I. Silverberg, Mercedes E. Gonzalez, Lynda C. Schneider, Robert Sidbury, Zhen Chen, Ashish Bansal, Zhixiao Wang, and Randy Prescilla
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: results from a placebo-controlled, phase 3 study, Amy S. Paller, Jonathan I. Silverberg, Eric L. Simpson, Michael J. Cork, Peter D. Arkwright, Zhen Chen, Ashish Bansal, Randy Prescilla, Zhixiao Wang, and Ainara R. Marco
Evaluating the Content and Quality of the Top 50 #Cosmeticdermatology Instagram Posts, Vincent A. Pecora, Erika T. McCormick, Alexis E. Carrington, and Pooja Sodha
Targeting sebaceous glands: a review of selective photothermolysis for Acne Vulgaris treatment, Anika Pulumati, Dana Jaalouk, Yanci A. Algarin, Eli Kasheri, Naiem T. Issa, and Keyvan Nouri
Dermatologic Conditions in Down Syndrome: A Multi-Site Retrospective Review of International Classification of Diseases Codes, Tasya Rakasiwi, Chenin Ryan, Amy Stein, Alan Vu, Morgan Dykman, Ipsit Shah, Catherine Reilly, Gabrielle Brokamp, Mia A. Mologousis, Bailey Komishke, Vincent Hou, Sheilagh Maguiness, A Yasmine Kirkorian, Harper Price, Elena B. Hawryluk, Esteban Fernandez Faith, Irene Lara-Corrales, Emily Gurnee, Kristen E. Holland, and Jillian F. Rork
Occupational Contact Dermatitis in Construction Workers: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2020, Margo J. Reeder, Alexander Idrogo-Lam, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Jonathan I. Silverberg, Brandon L. Adler, Amber R. Atwater, James S. Taylor, Marie-Claude Houle, Donald V. Belsito, Jiade Yu, Nina Botto, Christen M. Mowad, Cory A. Dunnick, Vincent A. DeLeo, and Melanie D. Pratt
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019-2020, Margo J. Reeder, Aman Nihal, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Amber R. Atwater, Marie-Claude Houle, Brandon L. Adler, Jonathan I. Silverberg, James S. Taylor, Melanie D. Pratt, Donald V. Belsito, Jiade Yu, Nina B. Botto, Chris M. Mowad, Cory A. Dunnick, and Vincent A. DeLeo
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients, Yael Renert-Yuval, Khaled Ezzedine, Pearl Grimes, David Rosmarin, Lawrence F. Eichenfield, Leslie Castelo-Soccio, Victor Huang, Seemal R. Desai, Samantha Walsh, Jonathan I. Silverberg, Amy S. Paller, Michele Rodrigues, Mark Weingarten, Shanthi Narla, Jackie Gardner, Michael Siegel, Sidra Ibad, and Nanette B. Silverberg
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study, Amalie Thorsti Rønnstad, Mia-Louise Nielsen, Christoph Schlapbach, Emma Guttman-Yassky, Jonathan I. Silverberg, Simon Francis Thomsen, Jacob P. Thyssen, and Alexander Egeberg
Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making, Archana Samynathan and Jonathan I. Silverberg
A review of hair removal modalities in pediatric patients: Ethical and clinical considerations, Eric Sanfilippo, Leslie Castelo-Soccio, and Anna Yasmine Kirkorian
A scalable approach to assess the safety of recently marketed systemic treatments for atopic dermatitis in clinical practice, Maria C. Schneeweiss, Robert J. Glynn, Richard Wyss, Priyanka Anand, Yinzhu Jin, Joan Landon, Arash Mostaghimi, Joseph F. Merola, Jonathan I. Silverberg, David M. Rosmarin, Robert Sidbury, and Sebastian Schneeweiss
Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2), J I. Silverberg, M N. Mustapa, F Reid, A Lei, R Smith, R Moate, A Kelly, R Chen, M Gavala, E Jimenez, M G. Belvisi, M W. Sadiq, C Kell, and H C. Pandya
Validation of the Investigator Global Assessment of Chronic Hand Eczema (IGA-CHE): a new clinician reported outcome measure of CHE severity, Jonathan I. Silverberg, Tove Agner, Keith Baranowski, Ursula Plohberger, Henrik Thoning, Rob Arbuckle, Laura Grant, George Skingley, and Robert Bissonnette
Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb/IV study (Level Up), Jonathan I. Silverberg, Christopher G. Bunick, H Chih-Ho Hong, Pedro Mendes-Bastos, Linda Stein Gold, Antonio Costanzo, Nadia Ibrahim, Cristina Sancho, Xiaoqiang Wu, Yu Han, Gweneth Levy, Kathy Altman, Brian Calimlim, and Kilian Eyerich
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up), Jonathan I. Silverberg, Christopher G. Bunick, H Chih-Ho Hong, Pedro Mendes-Bastos, Linda Stein Gold, Antonio Costanzo, Nadia Ibrahim, Cristina Sancho, Xiaoqiang Wu, Yu Han, Gweneth Levy, Kathy Altman, Brian Calimlim, and Kilian Eyerich
Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry, Jonathan I. Silverberg, Brian M. Calimlim, Ayman Grada, Christopher G. Bunick, Melinda J. Gooderham, Vivian Y. Shi, Chibuzo Obi, Keith D. Knapp, Breda Munoz, Julie M. Crawford, and Amy S. Paller
Characterization of disease burden, treatment and comorbidities in a large, real-world cohort of patients with atopic dermatitis: The CorEvitas Atopic Dermatitis Registry, Jonathan I. Silverberg, Angel Cronin, Eric A. Jones, Swapna S. Dave, Robert R. McLean, Jeffrey Greenberg, Bruce Strober, Thomas Bieber, Melinda Gooderham, Amy S. Paller, and Eric L. Simpson
Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis in Adults and Children Down to 2 Years of Age in the Pivotal Phase 3 ADORING Trials, Jonathan I. Silverberg, Lawrence F. Eichenfield, Adelaide A. Hebert, Eric L. Simpson, Linda Stein Gold, Robert Bissonnette, Kim A. Papp, John Browning, Pearl Kwong, Neil J. Korman, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli, Matthew C. Somerville, Anna M. Tallman, and Leon Kircik
Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry, Jonathan I. Silverberg, Linda Stein Gold, Seemal Desai, Alexandra Golant, Douglas DiRuggiero, D Christian Fenske, Alvin Li, Zach Dawson, Yolanda Muñoz Maldonado, Kaylee Ho, Kayla Callahan, and Eric L. Simpson
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2), Jonathan I. Silverberg, Melinda J. Gooderham, Amy S. Paller, Mette Deleuran, Christopher G. Bunick, Linda F. Gold, DirkJan Hijnen, Brian M. Calimlim, Wan-Ju Lee, Henrique D. Teixeira, Xiaofei Hu, Shiyu Zhang, Yang Yang, Ayman Grada, Andrew M. Platt, and Diamant Thaçi
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis, Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Marius Rademaker, Daria Fomina, Jan Gutermuth, Jiyoung Ahn, Fernando Valenzuela, Mahreen Ameen, Martin Steinhoff, Mark G. Kirchhof, Peter Lio, and Andreas Wollenberg
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study, Jonathan I. Silverberg, Robert S. Kirsner, David J. Margolis, Michael Tharp, Daniela E. Myers, Karen Annis, Daniela Graham, Chuanbo Zang, Bonnie L. Vlahos, and Paul Sanders
Patch Testing With Nickel, Cobalt, and Chromium in Patients With Suspected Allergic Contact Dermatitis, Jonathan I. Silverberg, Nisha Patel, Erin M. Warshaw, Joel G. DeKoven, Donald V. Belsito, Amber R. Atwater, James S. Taylor, Denis Sasseville, Margo J. Reeder, Marie-Claude Houle, Vincent A. DeLeo, Howard I. Maibach, Joseph F. Fowler, Kathryn A. Zug, Melanie D. Pratt, JiaDe Yu, Christen M. Mowad, Nina C. Botto, and Brandon L. Adler
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials, Jonathan I. Silverberg, David Rosmarin, Raj Chovatiya, Thomas Bieber, Stephen Schleicher, Lisa Beck, Melinda Gooderham, Sohail Chaudhry, Christie Fanton, Danni Yu, Joshua Levy, Yi Liu, Takahiro Miyazaki, Mary Tagliaferri, Carsten Schmitz, Ajay Nirula, Brian Kotzin, and Jonathan Zalevsky
Phosphorylated p38 MAP kinase expression by leucocytes is increased in allergic humans and associated with IgE responses, Jonathan I. Silverberg, Tamar A. Smith-Norowitz, Stephan Kohlhoff, and Rauno Joks
Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4Rα, in adults with moderate to severe atopic dermatitis: A phase 2 randomized trial (CBP-201-WW001), Jonathan I. Silverberg, Bruce Strober, Brian Feinstein, Jinhua Xu, Emma Guttman-Yassky, Eric L. Simpson, Pauline Li, Malinda Longphre, Jing Song, Jiawang Guo, Jang Yun, Belinda Williams, Wubin Pan, Selwyn Ho, Raúl Collazo, and Zheng Wei
Abrocitinib may improve itch and quality of life in patients with itch-dominant atopic dermatitis, Jonathan I. Silverberg, Jacob P. Thyssen, Irina Lazariciu, Daniela E. Myers, Erman Güler, and Raj Chovatiya
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials, Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J. Legat, Kim A. Papp, Linda Stein Gold, Jean-David Bouaziz, Andrew E. Pink, José Manuel Carrascosa, Barbara Rewerska, Jacek C. Szepietowski, Dorota Krasowska, Blanka Havlíčková, Monika Kalowska, Nina Magnolo, Sylvia Pauser, Navid Nami, Maxwell B. Sauder, Vipul Jain, Kamila Padlewska, Soo Yeon Cheong, Patricia Fleuranceau Morel, Liliana Ulianov, and Christophe Piketty
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials, Jonathan I. Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J. Legat, Kim A. Papp, Linda Stein Gold, Jean-David Bouaziz, Andrew E. Pink, José Manuel Carrascosa, Barbara Rewerska, Jacek C. Szepietowski, Dorota Krasowska, Blanka Havlíčková, Monika Kalowska, Nina Magnolo, Sylvia Pauser, Navid Nami, Maxwell B. Sauder, Vipul Jain, Kamila Padlewska, Soo Yeon Cheong, Patricia Fleuranceau Morel, Liliana Ulianov, and Christophe Piketty
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment, Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, Jose-Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline Pierce, Helena Agell, and Sonja Ständer
Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment, Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, James Del Rosso, Gil Yosipovitch, Peter Lio, Jose-Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline Pierce, Helena Agell, and Sonja Ständer
VINDICATE-P: A Mnemonic for the Many Comorbidities of Atopic Dermatitis, Nanette B. Silverberg, Mary F. Lee-Wong, and Jonathan I. Silverberg
Atopic Dermatitis: The Era of Excellence in Care, Nanette B. Silverberg and Jonathan I. Silverberg
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis, Eric L. Simpson, Marjolein de Bruin-Weller, H Chih-Ho Hong, Delphine Staumont-Sallé, Andrew Blauvelt, Kilian Eyerich, Melinda Gooderham, Mona Shahriari, Lotus Mallbris, Amber Reck Atwater, Maria Jose Rueda, Yuxin Ding, Zhuqing Liu, Helena Agell, and Jonathan I. Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2), Eric L. Simpson, Vimal H. Prajapati, Yael A. Leshem, Raj Chovatiya, Marjolein S. de Bruin-Weller, Sonja Ständer, Andrew E. Pink, Brian M. Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M. Platt, and Jonathan I. Silverberg
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure, Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, and Kanti Chittuluru
Integrated Safety Update of Abrocitinib in 3802 Patients with Moderate-to-Severe Atopic Dermatitis: Data from More than 5200 Patient-Years with Up to 4 Years of Exposure, Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, and Kanti Chittuluru
Dupilumab treatment improves signs, symptoms, quality of life and work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial, Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Sygula, Marie L. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ariane Dubost-Brama, and Ashish Bansal
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial, Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Syguła, Marie L. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ariane Dubost-Brama, and Ashish Bansal
A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating, Stacy Smith, Dee Anna Glaser, Lawerence J. Green, Micheal S. Kaminer, Erin Tims, and David M. Pariser
A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating, Stacy Smith, Dee Anna Glaser, Lawerence J. Green, Micheal S. Kaminer, Erin Tims, and David M. Pariser
The big picture: Terminology in laser medicine, Pooja Sodha, Jordan V. Wang, Roy G. Geronemus, and Paul M. Friedman
The big picture: Terminology in laser medicine, Pooja Sodha, Jordan V. Wang, Roy G. Geronemus, and Paul M. Friedman
Landscape of social networking support groups for common dermatological conditions, Audrey Terrany, Bianca Sanabria, Bassem Rafiq, and Babar Rao
Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN, J P. Thyssen, J I. Silverberg, J Ruano, A Blauvelt, W Gubelin, E L. Simpson, S Weidinger, H Valdez, K K. Terry, P Biswas, E Güler, and C Feeney
Lack of association of atopic dermatitis severity and morphology with asthma onset and control, Savanna I. Vidal and Jonathan I. Silverberg
Cross-sectional study of phenotypical differences of atopic dermatitis in Asian vs. White patients in the United States, Vincent Wan and Jonathan I. Silverberg
Patch Testing to Mentha piperita (Peppermint) Oil: The North American Contact Dermatitis Group Experience (2009-2020), Erin M. Warshaw, Malina Yamashita Peterson, Joel G. DeKoven, Brandon L. Adler, Melanie D. Pratt, Donald V. Belsito, Amber R. Atwater, Marie-Claude Houle, Cory A. Dunnick, Jiade Yu, James S. Taylor, Jonathan I. Silverberg, Margo J. Reeder, Vincent A. DeLeo, Christen Mowad, and Nina C. Botto
Association of chronic kidney disease with hidradenitis suppurativa: A retrospective study, Chapman Wei, Ahmad Mustafa, John Strange, Radu Grovu, Theodore Strange, Adam J. Friedman, Stefan Bradu, Amit Garg, and Suzanne E. El-Sayegh
The Skin Microbiome and its Significance for Dermatologists, Cleo Whiting, Sara Abdel Azim, and Adam Friedman
The Skin Microbiome and its Significance for Dermatologists, Cleo Whiting, Sara Abdel Azim, and Adam Friedman
A cross-sectional survey of clinical trials knowledge, participation, and perspectives in an underserved community of Washington, DC, Cleo Whiting, Deega Omar, Sarah Millan, Andeulazia Murdock, Sara Abdel Azim, and Adam Friedman
Patient-reported burden in adults with atopic dermatitis: an international qualitative study, Andreas Wollenberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, and Jonathan I. Silverberg
A Review of Best Practices for Gender-Affirming Laser Hair Removal, Daniel A. Yanes, Payton Smith, and Mathew M. Avram
Epidemiologic trends in cutaneous squamous cell carcinoma from 2011 to 2021 at All Africa Leprosy, Tuberculosis, and Rehabilitation Training Center (ALERT) in Addis Ababa, Ethiopia, Tizita Yosef, Wondwossen Ergete, Rishab R. Revankar, Heli A. Patel, Tsegaye Hailu Kumsa, Vishal A. Patel, Selfu Girma, and Benjamin K. Stoff
Submissions from 2023
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity, Gabriela C. Baiocchi, Aristo Vojdani, Avi Z. Rosenberg, Elroy Vojdani, Gilad Halpert, Yuri Ostrinski, Israel Zyskind, Igor S. Filgueiras, Lena F. Schimke, Alexandre H. Marques, Lasse M. Giil, Yael B. Lavi, Jonathan I. Silverberg, Jason Zimmerman, Dana A. Hill, Amanda Thornton, Myungjin Kim, Roberta De Vito, Dennyson L. Fonseca, Desireé R. Plaça, Paula P. Freire, Niels O. Camara, Vera L. Calich, Carmen Scheibenbogen, Harald Heidecke, Miriam T. Lattin, Hans D. Ochs, Gabriela Riemekasten, Howard Amital, Yehuda Shoenfeld, and Otavio Cabral-Marques
Efficacy and Safety of Microencapsulated Benzoyl Peroxide Cream, 5%, in Rosacea: Results From Two Phase III, Randomized, Vehicle-Controlled Trials, Neal D. Bhatia, Wm Philip Werschler, Hilary Baldwin, Jeffrey Sugarman, Lawrence J. Green, Ofra Levy-Hacham, Ori Nov, Vered Ram, and Linda Stein Gold
Estimands for atopic dermatitis clinical trials: expert opinion on the importance of intercurrent events, R Bissonnette, L F. Eichenfield, E Simpson, D Thaçi, K Kabashima, J P. Thyssen, E Guttman-Yassky, F P. Nunes, M Gamalo, F Ahmad, M Kuligowski, K Sun, C Pipper, A W. Christensen, P D'Angelo, M Milutinovic, A Guettner, and J I. Silverberg
The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council, Robert Bissonnette, Eric Simpson, Lawrence F. Eichenfield, Emma Guttman-Yassky, Jonathan I. Silverberg, Lisa A. Beck, Lorena Mija, Jacob P. Thyssen, Thomas Bieber, Kenji Kabashima, Elaine Siegfried, Georg Stingl, Peter van de Kerkhof, Gil Yosipovitch, Carle Paul, and Amy S. Paller
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review, Andrew Blauvelt, Richard G. Langley, Kenneth B. Gordon, Jonathan I. Silverberg, Kilian Eyerich, Morten O. Sommer, Jakob Felding, and Richard B. Warren
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative Review, Andrew Blauvelt, Richard G. Langley, Kenneth B. Gordon, Jonathan I. Silverberg, Kilian Eyerich, Morten O. Sommer, Jakob Felding, and Richard B. Warren
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials, Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman-Yassky, Thomas Bieber, Esther Serra-Baldrich, Eric Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R. Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther Garcia Gil, and Jonathan I. Silverberg
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials, Andrew Blauvelt, Jacob P. Thyssen, Emma Guttman-Yassky, Thomas Bieber, Esther Serra-Baldrich, Eric Simpson, David Rosmarin, Hany Elmaraghy, Eric Meskimen, Chitra R. Natalie, Zhuqing Liu, Chenjia Xu, Evangeline Pierce, MaryAnn Morgan-Cox, Esther Garcia Gil, and Jonathan I. Silverberg
Atopic dermatitis yardstick update, Mark Boguniewicz, Luz Fonacier, Emma Guttman-Yassky, Peck Y. Ong, and Jonathan I. Silverberg
Ulcerated diaper dermatitis: Child abuse mimicker, Stella A. Caldas, Emily Murphy, Kaiane Habeshian, Anna Yasmine Kirkorian, and Tanya Hinds
Mental Health Interventions for Atopic Dermatitis: Knowledge Gaps, Pilot Programs, and Future Directions, Sheena Chatrath, Jennifer LeBovidge, Carolyn Jack, Katrina Abuabara, Lynda C. Schneider, Korey Capozza, Keri Kelley, and Jonathan I. Silverberg
Phenotypic differences of atopic dermatitis stratified by age, Sheena Chatrath and Jonathan I. Silverberg
Patients' and Caregivers' Preferences for Mental Health Care and Support in Atopic Dermatitis, Albert C. Chong, Alan Schwartz, Jessica Lang, Peck Y. Ong, Ian A. Myles, Jonathan I. Silverberg, and Korey Capozza
Trends in Health Care Utilization Among United States Children With Eczema by Age, Sex, Race, and Hispanic Ethnicity: National Health Interview Survey 2006-2018, Siri Choragudi, Luis F. Andrade, Jonathan Silverberg, and Gil Yosipovitch
The financial burden of out-of-pocket healthcare expenses on caregivers of children with atopic dermatitis in the United States, Raj Chovatiya, Wendy Smith Begolka, Isabelle J. Thibau, and Jonathan I. Silverberg
Prevalence of and association between atopic dermatitis and food sensitivity, food allergy and challenge-proven food allergy: A systematic review and meta-analysis, M O. Christensen, Y A. Barakji, N Loft, C M. Khatib, A Egeberg, S F. Thomsen, J I. Silverberg, C Flohr, J T. Maul, P Schmid-Grendelmeier, A S. Halling, I Vittrup, and J P. Thyssen
Systemic treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials, Alexandro W. Chu, Melanie M. Wong, Daniel G. Rayner, Gordon H. Guyatt, Juan Pablo Martinez, Renata Ceccacci, Irene X. Zhao, Eric McMullen, Archita Srivastava, Jason Wang, Aaron Wen, Fang Chi Wang, Romina Brignardello-Petersen, Ariel Izcovich, Paul Oykhman, Kathryn E. Wheeler, Julie Wang, Jonathan M. Spergel, Jasvinder A. Singh, Jonathan I. Silverberg, Peck Y. Ong, Monica O'Brien, Stephen A. Martin, Peter A. Lio, Mary Laura Lind, Jennifer LeBovidge, Elaine Kim, Joey Huynh, Matthew Greenhawt, Donna D. Gardner, Winfred T. Frazier, and Kathy Ellison
Topical treatments for atopic dermatitis (eczema): systematic review and network meta-analysis of randomized trials, Derek K. Chu, Alexandro W. Chu, Daniel G. Rayner, Gordon H. Guyatt, Juan José Yepes-Nuñez, Luis Gomez-Escobar, Lucia C. Pérez-Herrera, Juan Pablo Díaz Martinez, Romina Brignardello-Petersen, Behnam Sadeghirad, Melanie M. Wong, Renata Ceccacci, Irene X. Zhao, John Basmaji, Margaret MacDonald, Xiajing Chu, Nazmul Islam, Ya Gao, Ariel Izcovich, Rachel N. Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Korey Capozza, Lina Chen, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Jennifer LeBovidge, Peter A. Lio, Stephen A. Martin, and Monica O'Brien
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K. Chu, Lynda Schneider, Rachel Netahe Asiniwasis, Mark Boguniewicz, Anna De Benedetto, Kathy Ellison, Winfred T. Frazier, Matthew Greenhawt, Joey Huynh, Elaine Kim, Jennifer LeBovidge, Mary Laura Lind, Peter Lio, Stephen A. Martin, Monica O'Brien, Peck Y. Ong, Jonathan I. Silverberg, Jonathan M. Spergel, Julie Wang, Kathryn E. Wheeler, and Gordon H. Guyatt
Mpox-A Rapidly Evolving Disease, Edward W. Cowen, Eric R. Tkaczyk, Scott A. Norton, and Kieron S. Leslie
Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies, Dawn M. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Robert Sidbury
Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies, Dawn M. Davis, Aaron M. Drucker, Ali Alikhan, Lionel Bercovitch, David E. Cohen, Jennifer M. Darr, Lawrence F. Eichenfield, Lindsy Frazer-Green, Amy S. Paller, Kathryn Schwarzenberger, Jonathan I. Silverberg, Anne Marie Singh, Peggy A. Wu, and Robert Sidbury
Efficacy and Safety of Microencapsulated Benzoyl Peroxide and Microencapsulated Tretinoin for the Treatment of Acne Vulgaris: Results from Two Phase 3 Double-Blind, Randomized, Vehicle-Controlled Studies, James Del Rosso, Jeffrey Sugarman, Lawrence Green, Theodore Lain, Ofra Levy-Hacham, Rinat Mizrahi, and Linda Stein Gold
Real-world clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study, Kilian Eyerich, Melinda J. Gooderham, Juan Francisco Silvestre, Stephen P. Shumack, Pedro Mendes-Bastos, Valeria Aoki, Michela Ortoncelli, Jonathan I. Silverberg, Henrique D. Teixeira, Shirley H. Chen, Brian M. Calimlim, Shunya Takemoto, Cristina Sancho, Björn Fritz, and Alan D. Irvine
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach, Dennyson Leandro Fonseca, Igor Salerno Filgueiras, Alexandre H. Marques, Elroy Vojdani, Gilad Halpert, Yuri Ostrinski, Gabriela Crispim Baiocchi, Desirée Rodrigues Plaça, Paula P. Freire, Shahab Zaki Pour, Guido Moll, Rusan Catar, Yael Bublil Lavi, Jonathan I. Silverberg, Jason Zimmerman, Gustavo Cabral-Miranda, Robson F. Carvalho, Taj Ali Khan, Harald Heidecke, Rodrigo J. Dalmolin, Andre Ducati Luchessi, Hans D. Ochs, Lena F. Schimke, Howard Amital, Gabriela Riemekasten, Israel Zyskind, Avi Z. Rosenberg, Aristo Vojdani, Yehuda Shoenfeld, and Otavio Cabral-Marques
JAAD Game Changers: Pityrosporum folliculitis: A retrospective review of 110 cases, Adam Friedman
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice, Melinda J. Gooderham, Andrew E. Pink, Eric L. Simpson, Jonathan I. Silverberg, Erman Güler, and Melissa Watkins
Silica-based microencapsulation used in topical dermatologic applications, Lawrence J. Green, Neal D. Bhatia, Ofer Toledano, Maya Erlich, Amy Spizuoco, Benjamin C. Goodyear, Jean Philippe York, and Jeannette Jakus
Silica-based microencapsulation used in topical dermatologic applications, Lawrence J. Green, Neal D. Bhatia, Ofer Toledano, Maya Erlich, Amy Spizuoco, Benjamin C. Goodyear, Jean Philippe York, and Jeannette Jakus
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo Bernard Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Suk-Young Yoo, Melissa Mathias, Hyunsil Han, Frank Seebach, Israel Lowy, Matthew G. Fury, and Danny Rischin
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study, Neil D. Gross, David M. Miller, Nikhil I. Khushalani, Vasu Divi, Emily S. Ruiz, Evan J. Lipson, Friedegund Meier, Yungpo Bernard Su, Paul L. Swiecicki, Jennifer Atlas, Jessica L. Geiger, Axel Hauschild, Jennifer H. Choe, Brett G. Hughes, Dirk Schadendorf, Vishal A. Patel, Jade Homsi, Janis M. Taube, Annette M. Lim, Renata Ferrarotto, Suk-Young Yoo, Melissa Mathias, Hyunsil Han, Frank Seebach, Israel Lowy, Matthew G. Fury, and Danny Rischin
Engagement, Retention and Acceptability in a Digital Health Program for Atopic Dermatitis: Prospective Interventional Study, Sigrídur Lára Gudmundsdóttir, Tommaso Ballarini, María L. Ámundadóttir, Judit Mészáros, Jenna Huld Eysteinsdottir, Ragna H. Thorleifsdottir, Sigrídur K. Hrafnkelsdóttir, Halla Helgadottir, Saemundur Oddsson, and Jonathan I. Silverberg